Statin and Aspirin Pretreatment Are Associated with Lower Neurological Deterioration and Platelet Activity in Patients with Acute Ischemic Stroke

详细信息    查看全文

• 作者：Xingyang Yi ; MD^* ; ^{yixingyang64@126.com} ; Zhao Han ; MD^&dagger ; ; ^{wzhanzhao@aliyun.com} ; Chun Wang ; MSc^* ; Qiang Zhou ; MD^&Dagger ; ; Jing Lin ; MD^&Dagger ;
• 关键词：Neurological deterioration ; platelet activation ; ischemic stroke ; outcome
• 刊名：Journal of Stroke and Cerebrovascular Diseases
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：26
• 期：2
• 页码：352-359
• 全文大小：126 K
• 卷排序：26

文摘

Aspirin and statin are recommended for the treatment of acute ischemic stroke. However, whether aspirin and statin pretreatment is associated with clinical outcomes has not been well addressed. This study aimed to evaluate the effect of pre-existing statin and aspirin use on platelet activation and clinical outcome in acute ischemic stroke patients.MethodsWe conducted a prospective, multicenter observational study in patients with acute ischemic stroke. Platelet aggregation and platelet–leukocyte aggregates were measured on admission and during 7-10 days after admission. The primary outcome of the study was neurological deterioration (ND) within 10 days after admission. The secondary outcome was a composite of recurrent ischemic stroke, myocardial infarction, and death during the first 3 months after admission. Physical disability was evaluated using the modified Rankin Scale score at 3 months after admission.ResultsAmong 1124 enrolled patients, 270 (24%) experienced ND. Higher platelet aggregation and platelet–leukocyte aggregates on admission and during 7-10 days were associated with ND. Platelet aggregation and platelet–leukocyte aggregates on admission were significantly lower in the patients with pre-existing statin or aspirin use than those without treatment. Patients with prestroke concomitant statin and aspirin treatment had significantly lower incidence of ND than those without treatment. Diabetes mellitus, fasting glucose, platelet–leukocyte aggregates, and prestroke concomitant statin and aspirin use were independently associated with ND.ConclusionsPrestroke concomitant statin and aspirin use is associated with lower neurological deterioration and platelet activity in patients with acute ischemic stroke.